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Abstract 
Background: Intrauterine growth restriction (IUGR) is a risk factor for hypertension (HT) and chronic renal disease 
(CRD). A reduction in the nephron number is proposed to be the underlying mechanism; however, the mechanism 
is debated. The aim of this study was to demonstrate that IUGR‑induced HT and CRD are linked to the magnitude of 
nephron number reduction, independently on its cause.
Methods: Systolic blood pressure (SBP), glomerular filtration rate (GFR), proteinuria, nephron number, and glomeru‑
lar sclerosis were compared between IUGR offspring prenatally exposed to a maternal low‑protein diet (9% casein; 
LPD offspring) or maternal administration of betamethasone (from E17 to E19; BET offspring) and offspring with a 
normal birth weight (NBW offspring).
Results: Both prenatal interventions led to IUGR and a similar reduction in birth weight. In comparison to NBW 
offspring, BET offspring had a severe nephron deficit (−50% in males and −40% in females, p < 0.01), an impaired 
GFR (−33%, p < 0.05), and HT (SBP+ 17 mmHg, p < 0.05). Glomerular sclerosis was more than twofold higher in BET 
offspring than in NBW offspring (p < 0.05). Long‑term SBP, GFR, and glomerular sclerosis were unchanged in LPD 
offspring while the nephron number was moderately reduced only in males (−28% vs. NBW offspring, p < 0.05).
Conclusion: In this study, the magnitude of nephron number reduction influences long term renal disease in IUGR 
offspring: a moderate nephron number is an insufficient factor. Extremely long‑term follow‑up of adults prenatally 
exposed to glucocorticoids are required.
Keywords: IUGR, Low birth weight, Preterm infant, Nephron number, Prenatal glucocorticoids, Hypertension, 
Chronic kidney disease, Glomerular sclerosis
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Background
Epidemiological evidence shows that exposure to an 
adverse foetal environment, manifested in part by intra-
uterine growth restriction (IUGR), increases the risk 
of cardiovascular disease (CVD) and chronic renal dis-
ease (CRD) in adulthood [1–3]. Prevalence of chronic 
renal disease, defined as reduced glomerular filtration 
rate (GFR), proteinuria or both is increasing in several 
countries [4]. Such an association has been reproduced 
in animals from various species but not in all experimen-
tal studies which suggest that factors others than IUGR 
may be involved [5–8]. In rats, a maternal gestational 
low-protein diet (LPD) and prenatal administration of 
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synthetics glucocorticoids, namely betamethasone and 
dexamethasone, have been widely used to reproduce 
conditions of human IUGR [2, 9]. Both models share at 
least a common pathophysiological mechanism which is 
fetal overexposure to glucocorticoids. As demonstrated 
in human IUGR, maternal LPD is associated with fetal 
glucocorticoids overexposure due to down-regulation 
of placental type 2 11-β hydroxysteroid dehydroge-
nase (11β-HSD2) which inhibits transplacental transfer 
of maternal corticosterone [4]. Reduced transplacental 
amino-acid transfer has been shown in human IUGR as 
well [10, 11]. However most of the experimental studies 
included young adult offspring and long term patterns of 
blood pressure, renal functions and structure have been 
little investigated.
IUGR-induced hypertension and CRD are postulated 
to result from a nephron deficit [2, 12, 13]. In this case, 
according to the scheme of Brenner et al., single-nephron 
glomerular hyperfiltration (SNGHF) and glomerular 
hypertension occur to meet the excretory demands [14]. 
Over a long period, a vicious cycle occurs, leading to glo-
merular and tubular injury with proteinuria, glomerular 
sclerosis, impaired renal functions, and systemic hyper-
tension. However, recent findings question this patho-
physiological mechanism and suggest that a nephron 
deficit could be insufficient to induce systemic hyperten-
sion and CRD [15–19].
Using two different IUGR models (a maternal LPD and 
gestational administration of betamethasone (BET)), 
which led to a similar reduction in birth weight, we 
aimed to show how the size of the reduction in nephron 
endowment influenced renal functions and structure in 
ageing offspring.
Methods
Animals and ethical approval
All animal procedures were approved by the Institutional 
Animal Care and Use Committee of Aix-Marseille Uni-
versity and in accordance with the European Communi-
ties Council Directive (2010/63/EU). Male and female 
virgin Sprague–Dawley rats, with an initial weight of 
225–250  g, were used (purchased from Charles Riv-
ers, l’Abresle, France). After 2  weeks of acclimatization, 
males and females were mated overnight. The day on 
which sperm were seen in the vaginal smear was des-
ignated as day 1 of pregnancy. Rats were housed in a 
room with a 12-h light/dark cycle and maintained at a 
controlled temperature of 22 °C. They had free access to 
food and water. Pregnant rats were randomly assigned 
to the control group (normal gestation, n = 6) or one of 
two IUGR groups, namely, a maternal LPD (n = 6) and 
maternal administration of BET (n  =  6). The maternal 
LPD contained 9% casein (vs. 18% in control diet) and 
was fed ad  libitum during gestation. BET (0.25  mg/kg 
body weight) was administered intramuscularly at E17, 
E18 and E19. BET-administered pregnant rats were fed a 
normal diet ad libitum. After delivery, all dams were fed 
the same standard diet (18% casein). The weights of all 
pups were recorded within 6 h after delivery. The size of 
the litter was reduced to 10 pups, with the largest and the 
smallest pups removed, to ensure adequate and uniform 
nutrient supply to the pups. They were cared for by their 
mother until weaning on day 21, after which they were 
housed in groups of four. They had free access to water 
and the same standard laboratory rat chow. Offspring 
were weighed monthly until the end of experiments 
(22 months). For subsequent experiments, 2–3 male and 
female offspring were randomly selected from each litter.
Systolic blood pressure (SBP) measurement
SBP was determined non-invasively using tail cuff ple-
thysmography (Letica 5000, Bioseb, France) and ther-
mostatically warmed restrainers designed for rodents. 
This method has been extensively validated in rodents 
and refined to reduce possible stress-related effects. 
Each animal was acclimatized to this procedure over 5 
successive days (10  min per day). Thereafter, measure-
ments were performed by a single operator. The mean of 
4–6 measurements was recorded for each animal. SBP 
was measured at postnatal month 1, 4, 8, 12, 15 and 22. 
Unfortunately BP measurements in 22-month old off-
spring were inadequate and unusable due to unfit size of 
the tail cuff; also we decided not to consider the data.
Determination of renal function
Endogenous creatinine clearance (ClCr) and the daily 
urinary protein excretion rate (UprV) were determined 
in 8-, 12-, and 15-month-old offspring as ClCr = UCr V/
Pcr, where Ucr and Pcr designate the urinary and plasma 
creatinine concentrations, respectively, and V is the uri-
nary output. Animals were housed individually for 48 h 
in metabolic cages. Urine excreted over 24 h and blood 
samples from the lateral tail vein were collected under 
brief general anaesthesia (isoflurane Belamont). Blood 
samples were then transferred to heparinized tubes and 
centrifuged at 3000 rev/min for 15  min at 4  °C. In 22 
month-old animals urinary protein/creatinine ratio were 
assessed after anaesthesia. Plasma creatinine, urinary 
creatinine, and protein concentrations were measured 
using a standard autoanalyzer (Synchron LX 20 autoana-
lyzer, Beckman Coulter). The plasma creatinine concen-
tration was determined by the method of Jaffé.
Parameters of the renal structure
Nephron number and renal structure were evaluated in 
1 day-old and in 22-month-old offspring from the three 
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experimental groups. Animals were anaesthetised by 
intraperitoneal administration of pentobarbital sodium 
(60  mg/kg) with isoflurane inhalation. The left kidney 
was rapidly harvested, weighed, and decapsulated for glo-
merular counting, while the right kidney was removed, 
weighed, and kept for histology. In pups, mature and 
immature (S shape) nephrons were counted. Because 
gender was difficult to determine in 1 day-old pups and 
in order to avoid bias we decided not to express nephron 
number according to gender at that age. The number of 
glomeruli per kidney was determined using the dissec-
tion-maceration acid method as described previously 
[20]. Briefly, whole kidneys were incubated in 50% hydro-
chloric acid at 37 °C for time varying according the kid-
ney weight (30–45  min). Kidneys were rinsed with tap 
water and stored overnight at 4 °C in a gauged flask. Fol-
lowing mechanical dissociation, tubules and glomeruli 
were suspended in water. Three 0.5-ml aliquots were 
taken and placed in a hemocytometer-like chamber. Glo-
meruli were counted under a microscope by three inves-
tigators who were unaware of the specimen’s origin. The 
three results were then averaged and the mean value was 
used to determine the total number of glomeruli in the 
sample and therefore the kidney.
Renal histology and corresponding parameters were 
analysed by a single investigator (L.D.) with no prior 
knowledge of the group to which the rats belonged. 
One-half of the right kidney was fixed in 4% buffered for-
maldehyde. The kidneys were then dehydrated using a 
graded alcohol series and embedded in paraffin. Trans-
verse sections through the central portion of each kid-
ney and 4-µm thick sections stained with haematoxylin 
and eosin were obtained for light microscopic examina-
tion. In each single section of the kidney, all glomeruli 
(i.e., superficial and juxtamedullary) sectioned through 
the hilum were counted. More than 80 glomerular cross-
sections were analysed per group. The profile of a glo-
merulus was captured and the perimeter of the Bowman’s 
capsule was traced using a tablet cursor. The cross-sec-
tional tuft area was calculated for each glomerulus with 
a visible vascular pole using image analysis (SAMBA 
2005, Alcatel, TTITN Answare, France). The glomeru-
lar volume was then calculated assuming the glomerulus 
was spherical by applying the following mathematical 
equation: GV = β/k × (GA)3/2, where β is the shape coef-
ficient for a sphere (1.38), and k is the size distribution 
coefficient (1.1) [20]. Glomerular sclerosis was evaluated 
using Sirius red staining to visualise fibrillar collagen. 
Sirius red-stained fibrillar collagen as a percentage of the 
total glomerular surface area was thus determined. A sin-
gle examiner (L.D.) performed this quantitative analysis 
using the same colorimetric and light thresholds (NCSS 
2004 software, Kaysville, Utah, USA). A colour threshold 
was applied to identify the red-stained structures. The 
results were reported as the mean ratio of Sirius red-
stained areas to total glomerular capillary areas.
Statistical analysis
All data are presented as mean ± SEM and were evalu-
ated for statistical significance using Statview version 5.0 
software (Abacus Concepts Inc, Berkeley, USA). Normal 
distribution was verified using Kolmogorov–Smirnov 
test. Data for BP, GFR and proteinuria were analysed 
using 2 way ANOVA testing groups, postnatal age and 
groups ×  postnatal age interaction with Bonferoni post 
hoc analysis when appropriate. Body weight, renal struc-
ture parameters were compared between groups using 
one-way ANOVA with Student–Newman–Keuls com-
parison test for post hoc analysis. Male and female off-
spring were analysed separately. The interaction between 
group and sex was firstly evaluated and showed a sex 
effect for body weight, BP, parameter of renal functions 
and structure. A p value  <0.05 was considered statisti-
cally significant.
Results
Birth weight and postnatal growth
Offspring prenatally exposed to maternal administra-
tion of BET (BET offspring) or a maternal LPD (LPD 
offspring) appeared healthy, although their birth weights 
were lower than those of control pups [normal birth 
weight (NBW) offspring] (6.47  ±  0.2, 5.08  ±  0.1, and 
5.26 ± 0.1 g for NBW, LPD, and BET offspring, respec-
tively; p < 0.001). The birth weights of LPD and BET off-
spring did not differ. The litter size and gender ratio were 
unaffected for both LPD and BET offspring (13  ±  2.2, 
12 ± 2.5, and 14 ± 3 pups per litter for NBW, LPD, and 
BET offspring, respectively).
At the end of the suckling period, BET offspring 
remained lighter than LPD and NBW offspring 
(57.3 ± 1.1, 49.4 ± 0.9, and 41.8 ± 1.1 g for NBW, LPD, 
and BET offspring, respectively; group effect; p  <  0.01; 
gender effect, p < 0.001; combined effect, p < 0.001). At 
the end of the study, when rats reached adulthood, the 
mean body weight of males NBW (703  ±  173  g) LPD 
(632 ± 151 g) and BET (617 ± 181 g) and females NBW 
(504 ± 141 g), LPD (484 ± 120 g), and BET (472 ± 149 g) 
offspring did not differ (group effect, p  =  0.12; gender 
effect, p < 0.01; combined effect, n.s).
Systolic blood pressure (SBP)
During the experimental period changes in SBP differed 
among the three groups (Fig. 1). SBP increased over the 
experimental period for both male and female offspring 
(postnatal age effect p  <  0.001). SBP was transiently 
higher in LPD male offspring than in NBW offspring at 
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4 and 8  months of age (p  <  0.05) but was unaltered in 
female LPD offspring. By contrast, female and male BET 
offspring had significant HT when 15  month-old. SBP 
was 15 and 17  mmHg higher in female and male BET 
offspring, respectively, than in NBW and LPD offspring 
(p < 0.05).
Renal function
Clearance of creatinine (ClCr) and proteinuria (UprV) 
data are shown in Fig.  2. ClCr declined progressively 
with age in both males and females offspring (postna-
tal age effect p < 0.001). At 12 months of age, ClCr was 
33% lower in BET male offspring than in NBW and 
LPD offspring (p  <  0.05). Proteinuria was significantly 
increased in BET male offspring. ClCr and proteinuria 
were unaltered in LPD offspring. In 22 month-old off-
spring urinary protein/creatinine ratio (g/g) were signifi-
cantly higher in BET offspring than other animals with 
1.85 ±  0.1, 2.01 ±  0.08 and 3.06 ±  0.08 in male NBW, 
LPD and BET offspring respectively and 1.43  ±  0.1, 
1.41 ± 0.06, 1.71 ± 0.1 in female NBW, LPD and BET off-
spring respectively (group effect p < 0.001; gender effect 
p < 0.001; combined effect p < 0.01).
Renal structure
The parameters of renal structure in 22-month-old age-
ing offspring are summarized in Fig.  3. The relative kid-
ney weight to body weight did not differ among the three 
groups, regardless of gender (2.06 ± 0.1, 2.01 ± 0.1, and 
1.90 ± 0.2 for NBW, LPD, and BET offspring, respectively; 
groups and gender effects, n.s.). Nephron number was 
moderately reduced in male LPD offspring (−28% vs. 
male NBW offspring, p  <  0.05) while it was unchanged 
in female LPD offspring. In comparison with male and 
female NBW offspring BET offspring showed 50 and 40% 
lower nephron number respectively (p < 0.001). Nephron 
number remained 22% (p < 0.05) and 45% (p < 0.01) lower 
in male and female BET offspring than LPD offspring. 
Such differences were already observed in 1  day-old 
pups when nephron number was more severely reduced 
in BET pups: 10488 ± 589, 6302 ± 223 and 5114 ± 145 
in NBW, LPD and BET offspring respectively (p < 0.01). 
Renal morphology, including glomerular volume and glo-
merular sclerosis, was unchanged in 22-month-old male 
and female LPD offspring. But glomerular sclerosis was 
respectively 3.5-fold (p  <  0.001) and twofold (p  <  0.05) 
higher in male and female BET offspring than in NBW 
and LPD offspring (Fig. 3B and Fig. 4).
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Fig. 1 Long term hypertension in IUGR‑BET offspring. Systolic blood 
pressure (SBP) of normal birth weight (NBW, open bars), maternal low‑
protein diet (LPD, grey bars), and BET (black bars) offspring from 1 to 
15 months after birth, according to gender. Values are mean ± SEM; 
(n = 10–12/group). Significance differences (p < 0.05) among groups 
are indicated by different letters (e.g., a is different from b but not 
from ab). Group effect <0.001, postnatal age effect <0.001, and com‑
bined effects <0.001
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Fig. 2 Renal functions in IUGR‑BET offspring more affected than in 
IUGR‑LPD offspring. Glomerular filtration rate [evaluated by clearance 
of creatinine (ClCr)] (A) and proteinuria (B) in normal birth weight 
(NBW, open bars), maternal low‑protein diet (LPD, grey bars), and BET 
(black bars) offspring at 8, 12, and 15 months after birth, according 
to gender. Values are mean ± SEM (n = 10–12/group). Significance 
differences (p < 0.05) among groups are indicated by different let-
ters (e.g., a is different from b). Group effect < 0.01, postnatal age 
effect <0.001, and combined effects <0.001
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Discussion
In this study, both prenatal interventions (a mater-
nal gestational LPD and a short course of BET 
administration during a specific period of gestation) 
induced a similar level of IUGR, but altered blood pres-
sure, renal functions, and renal structure differently. 
In comparison to LPD offspring, in which only males 
had a moderate nephron deficit and transient systemic 
hypertension, both male and female BET offspring had 
a severe nephron deficit, significant systemic hyperten-
sion, early renal dysfunction, and glomerular sclerosis. 
These findings suggest that a moderate reduction in 
nephron number alone is insufficient to induce these 
adult diseases. Although the pathological role of the kid-
ney is still debated, a severe nephron deficit significantly 
enhances the risk of long term chronic renal disease 
(CRD) related to IUGR.
Despite a similar reduction in birth weight, nephron 
number was significantly lower in BET offspring than 
in LPD offspring. The protective factor of female gen-
der commonly noted in LPD offspring was no longer 
observed in female BET offspring [21]. The last effect has 
not yet been reported. These findings confirm that short 
course of maternal gestational administration of gluco-
corticoids has specific effects on fetal nephrogenesis [22]. 
Betamethasone administered to pregnant dams crosses 
the placenta without being metabolized by the 11β-HSD2 
and reaches the fetal kidney. The subsequent effects are 
highly significant when GCs are administered during the 
early stage of nephrogenesis [22, 23]. They are known 
to accelerate maturation at the expense of cell prolifera-
tion and to induce apoptosis. Expression of various genes 
have been found to be modified in the kidney from both 
IUGR models leading to apoptosis especially of nephron 
precursors, arrested branching morphogenesis and accel-
erated tubular maturation [24–27]. We also shown huge 
alterations in various genes especially involved in coagu-
lation and inflammation pathways [28]. Inhibition of glu-
cocorticoids production prevent nephron deficit in LPD 
rat offspring which strengthens the pathophysiological 
role of fetal overexposure to glucocorticoids [29]. Find-
ings from our study and from other researchers, confirm 
that a short course of maternal administration of gluco-
corticoids at a specific time of gestation corresponding 
to early stage of nephrogenesis induces significant fetal 
nephron deficit.
A nephron deficit is proposed to be the mechanism 
linking IUGR and long-term systemic hypertension and 
CRD [10, 11, 30]. A nephron deficit is associated with 
pressure natriuresis re-setting and glomerular hemody-
namic adaptations. According to the scheme proposed 
by Brenner et al. single-nephron glomerular hyperfiltra-
tion occurs to meet excretory demands [14]. Subsequent 
glomerular hypertension causes glomerular injury. Over 
a long time, a vicious cycle occurs, leading to proteinu-
ria, glomerular sclerosis, impaired renal function, sodium 
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Fig. 3 Renal structure in IUGR‑BET offspring more affected than in 
IUGR‑LPD offspring. Nephron number (A), glomerular sclerosis (B), 
and mean glomerular volume (MGV; C) in 22‑month‑old normal birth 
weight (NBW, open bars), maternal low‑protein diet (LPD, grey bars), 
and BET (BET, black bars) offspring, according to gender (n = 8–12/
group). Glomerular sclerosis is expressed as the mean ratio of 
Sirius red‑stained areas to total glomerular capillary areas. Value are 
mean ± SEM; (n = 8–10). Significance differences (p < 0.05) among 
groups are indicated by different letters (e.g., a is different from b and 
c)
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retention and systemic hypertension. However, recent 
evidence questions this renal mechanism [13, 30, 31]. 
A nephron deficit is proposed to be a factor that con-
fers vulnerability when other postnatal factors, such as 
postnatal overfeeding, rapid catch-up growth or high 
salt intake, accelerate or induce these diseases [6, 16, 18, 
19]. We found that blood pressure, GFR and glomerular 
sclerosis were unaltered in LPD offspring with moderate 
nephron deficit suggesting that moderate nephron defi-
cit alone is insufficient to induce these diseases. However, 
the severity of nephron deficit regardless of the reduction 
of birth weight plays a critical role. In contrast with LPD 
offspring, BET offspring born with similar birth weight 
reduction exhibited significant systemic hypertension, 
progressive renal dysfunctions and glomerular sclerosis. 
Lack of significant glomerular hypertrophy despite severe 
nephron number reduction may result from diffuse glo-
merular sclerosis associated with glomerular retrac-
tion (through ischaemia) [32]. All of these alterations 
were moderate in female BET offspring and seemed to 
be shifted in time. It is possible that another time point 
would reveal more significant changes. The main differ-
ence between the two groups was that BET offspring had 
more severe nephron deficit, already present at birth, 
which preceded the occurrence of systemic hyperten-
sion and CRD. Moreover BET offspring had a progressive 
postnatal growth that excluded the detrimental effect of 
a rapid catch-up growth. All these findings demonstrate 
that the magnitude of nephron number reduction highly 
influences long term IUGR-induced systemic hyperten-
sion and CRD.
In the current study, IUGR offspring had similar birth 
weight reduction but displayed different blood pressure 
and renal functions patterns. Systemic hypertension 
was transient in male LPD offspring only, as previously 
reported, and occurred later in BET offspring [2]. One 
can propose that these blood pressure patterns at young 
adulthood result from differences in stress response asso-
ciated with blood pressure measurement. When using 
telemetry, the gold standard for measuring blood pres-
sure in awake animals, blood pressure levels have been 
reported unchanged in 5-month-old LPD offspring but 
significantly lower in 8-month-old offspring exposed pre-
natally to dexamethasone in comparison with NBW rat 
offspring [33, 34]. In our study, we used the same plethys-
mography device in all animals and repeated blood pres-
sure measurement at different ages might have reduced 
the stress of animals and limited biases. Further inves-
tigations are nevertheless required to evaluate differ-
ences in stress response between both IUGR models. In 
any case, all these findings justify very long term follow-
up of blood pressure and renal functions/structure in 
IUGR offspring and highlight differences between IUGR 
models.
a (males)
b (females)
NBW
NBW
IUGR-LPD
IUGR-LPD
IUGR-BET
IUGR-BET
Fig. 4 Histology of the kidney. Light microscopy examination of the cortical kidney of male (a) and female (b) normal birth weight (NBW), maternal 
low‑protein diet (LPD), and betamethasone (BET) offspring. Kidneys of BET offspring exhibit glomerular sclerosis with interstitial inflammation. 
Magnification ×200
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Our study has a few limitations. First we focused on 
the role of the kidney; however, other cardiovascular and 
metabolic systems known to drive the development of 
long term CVD may be differentially altered in both IUGR 
models [35, 36]. Impaired vascular structure, vascular 
endothelial dysfunction, increase sympathetic activity 
insulin resistance, hyper-leptinemia and hyperglycae-
mia have been reported in various IUGR models and in 
low birth weight infants. These functional and structural 
alterations promote systemic hypertension and in turn 
can affect renal functions and structure on the long term. 
But they are less likely to induce early renal dysfunctions 
in young BET offspring. Second we used clearance of cre-
atinine (ClCr) to measured GFR which enable follow-up 
of animals but might underestimate subtle renal changes 
in few animals. Third one can question on the role of the 
severity of nephron deficit on the occurrence of renal 
disease since nephron deficit observed in ageing animal 
might be due to nephron loss related to ageing process 
rather than reduced nephron endowment. However the 
fact that nephron deficit was already present at birth 
prior to the development of systemic hypertension and 
CRD strengthens the pathophysiological role of severe 
reduced nephron endowment. Finally two different IUGR 
models were used to investigate the pathophysiological 
role of the kidney. It is noteworthy that varying the inten-
sity of the prenatal insult (i.e., the amount of protein in 
the maternal gestational LPD or the dose of BET admin-
istered), may severely affect fetal growth and long term 
cardiovascular and renal functions and structure. The 
strength of our study was that IUGR-induced systemic 
hypertension and CRD were shown to be consequences 
of the severity of the nephron deficit, rather than the 
intensity of IUGR, because birth weight was similar in 
the two IUGR groups.
Clinical implications
Extrapolation from this study to human IUGR should be 
made with caution since current findings were observed 
in specific experimental models. However some evidence 
argues for the potential relevance of the IUGR mod-
els for human IUGR. In human IUGR is a consequence 
of maternal undernutrition as observed in the develop-
ing world or of placenta insufficiency and preeclampsia 
mainly observed in industrialized world [37]. Both ani-
mal and human subjects IUGR share striking similarities 
such as impaired maternal–fetal amino-acid transfer and 
reduced placental 11β-HSD2 [9–11]. Moreover, our find-
ings highlight the need for extremely long term follow-up 
of infants and adults exposed prenatally to glucocorti-
coids. Long term consequences are little known [38–40]. 
In pregnant women, glucocorticoids are prescribed for 
many reasons including acceleration of maturation of 
fetal lung in cases of threatened preterm labour, treat-
ment of connective tissue disorders, and women at risk 
of bearing fetus with congenital adrenal hyperplasia. In 
this last case, dexamethasone is administered from the 
first trimester to suppress fetal androgen overproduc-
tion. A short course of glucocorticoids prescribed for 
women at risk of preterm birth, reduces neonatal mortal-
ity and morbidity but may have long term consequences 
[41]. Maternal glucocorticoids administration, especially 
at high cumulative doses, can affect fetal growth [39]. A 
trend in reduction of GFR and markers of insulin resist-
ance have been reported in young adult born preterm 
and exposed prenatally to a short course of glucocorti-
coids as observed in experimental studies [39, 40]. These 
changes make them at high risk of cardiovascular and 
renal diseases.
Conclusion
In the current study, we demonstrated that a maternal 
gestational LPD and administration of BET both led to 
a similar level of IUGR. However, maternal gestational 
administration of BET during a specific period of gesta-
tion more severely affected nephron number and induced 
systemic hypertension, early renal dysfunctions, and glo-
merular sclerosis in ageing offspring. Renal functions and 
structure were unaltered in ageing LPD offspring, who 
had a moderate nephron deficit. These findings suggest 
that a moderate reduction in nephron number alone is 
not sufficient to induce cardiovascular and renal diseases. 
Although the pathological role of a nephron deficit is still 
debated, IUGR-induced long term systemic hyperten-
sion and CRD depends in large part on the magnitude 
of nephron number reduction. Our findings highlight 
the importance of developing early markers of nephron 
number dosing and the need for extremely long-term 
follow-up of adults exposed prenatally (or postnatally for 
preterm infants) to glucocorticoids, even if the current 
data are reassuring.
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